Up | AC
Home Page
Food and
Drug Administration
Circulatory System Devices Panel
October 10, 2007
BRIEFING INFORMATION
Sponsor
Medtronic Endeavor Zotarolimus-Eluting CSS
P060033
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily
agree with the sponsor's statements. FDA has not made a final
determination about the safety or effectiveness of the product
described in this document.
Medtronic Briefing Index (html)
FDA Briefing Materials
Disclaimer
The statements contained in this document(s) are those of
the product's sponsor, not FDA, and FDA does not necessarily
agree with the sponsor's statements. FDA has not made a final
determination about the safety or effectiveness of the product
described in this document.
FDA Executive Summary (pdf)